Lenvima 10 MG daily dose 30S
Ended Awarded
- Contract number
- SPE2DB25FWFDF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,354
Award facts
- Contract value 100% obligated
- $11,353.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,353.77 by the Defense Logistics Agency on September 26, 2025, for the supply of Lenvima 10 mg daily dose in quantities of 30 units. The contract carries no set-aside designation and is scheduled for completion by October 20, 2025, with performance taking place at the vendor's Park Ridge, Illinois location. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense medical facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure consistent contract awards from the Defense Logistics Agency. The company's portfolio demonstrates extensive experience distributing branded and generic prescription drugs, biologics, and medical consumables to military healthcare facilities. Lenvima, a targeted cancer therapy medication, aligns with the company's proven track record of supplying specialized pharmaceutical products, including oncology treatments and other high-value medications, directly to DoD healthcare sites across the nation.
Quick answers
Who was awarded contract SPE2DB25FWFDF?
SPE2DB25FWFDF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FWFDF worth?
The government has obligated $11,354 on SPE2DB25FWFDF.
Is contract SPE2DB25FWFDF an order under another contract?
Yes. SPE2DB25FWFDF is a delivery order under SPE2DB25D9320, an indefinite delivery contract.
Was contract SPE2DB25FWFDF competed?
The extent of competition for SPE2DB25FWFDF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award